Novateor Research Laboratories reported a net profit of ₹10.12 lakh for the financial year ended March 31, 2026, on a total income of ₹431.62 lakh. The company's board approved the audited standalone financial results for the year and half-year ended March 31, 2026, at a meeting held on May 30, 2026. However, the statutory auditor, H K Shah & Co., issued a qualified opinion, citing deviations from several accounting standards including inventory valuation, revenue recognition, and employee benefits.

The auditors noted that AS-2 (Valuation of Inventories) was not followed as the technical valuation claimed by the company was not quantifiable. Additionally, AS-9 (Revenue Recognition) was not adhered to, as interest income of ₹48.39 lakhs remains unrealized and under legal dispute, alongside ₹142.86 lakhs receivable from the previous year. The report also highlighted non-compliance with AS-15 (Employee Benefits) due to the absence of a provision for gratuity and AS-17 (Segment Reporting) as the company did not identify or report segment information.

For the year ended March 31, 2026, revenue from operations rose to ₹382.75 lakh from ₹277.73 lakh in the previous year. Total expenses increased to ₹420.27 lakh from ₹313.99 lakh. The company reported a basic earnings per share (EPS) of ₹0.17 for FY26, compared to ₹0.17 in the previous year. The half-year ended March 31, 2026, recorded a profit of ₹11.70 lakh, while the corresponding period in the previous year reported a profit of ₹4.86 lakh.

Financial Results for FY26

The auditors also drew attention to a revaluation of long-lease land at its fair market value of ₹100 lakhs, with a corresponding revaluation reserve of ₹30.15 lakhs. Furthermore, GST turnover aggregating to ₹9.83 lakhs is under reconciliation with the books of account. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the announcement of the audited financial results.

Novateor research laboratories Limited has announced the launch of its new oral care product, SmiloShine Herbafresh Toothpaste, formulated with 8 herbs. The company informed BSE Limited about this product launch under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, with the launch scheduled for April 30, 2026.

Product Launch Details

The SmiloShine Herbafresh Toothpaste launch represents part of Novateor Research Laboratories Limited's forward integration strategy. The product has been developed as an oral care FMCG product with a unique formulation containing 8 herbs, positioning it in the natural oral care segment.

Product Variants and Market Strategy

The company will introduce SmiloShine Herbafresh Toothpaste in two distinct variants designed to target different market segments:

• 6-gram pack: Specifically intended to enhance reach within the hotel and travel segment
• 100-gram pack: Aimed at expanding presence across the FMCG market in India as well as internationally

This dual-variant approach demonstrates the company's strategic focus on capturing both niche hospitality markets and mainstream consumer segments. The smaller 6-gram variant caters to the convenience and portability requirements of the travel industry, while the standard 100-gram pack targets regular household consumers.

Regulatory Compliance and Communication

Novateor Research Laboratories Limited has fulfilled its regulatory obligations by notifying BSE Limited about this product launch in accordance with Regulation 30 read with Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal communication was signed by Navdeep Mehta, Managing Director (DIN: 03441623), ensuring proper corporate governance protocols.

Market Positioning

The SmiloShine Herbafresh Toothpaste launch positions Novateor Research Laboratories Limited in the competitive oral care market with a focus on herbal formulations. The 8-herb formulation differentiates the product in a market increasingly focused on natural and herbal personal care products. The company's strategy to target both domestic and international markets indicates its ambition to establish a broader geographical presence in the oral care segment.